SomnoMed Limited
SOMNF
$0.4361
-$0.0487-10.05%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 98.34% | 98.30% | -36.69% | -33.32% | -67.94% |
| Total Depreciation and Amortization | 1.01% | 3.38% | 32.65% | 29.39% | 21.86% |
| Total Amortization of Deferred Charges | -- | -- | 6.13% | 3.50% | -- |
| Total Other Non-Cash Items | 210.54% | 213.11% | -65.11% | -65.98% | 44.53% |
| Change in Net Operating Assets | -- | -- | 66.32% | 67.15% | -- |
| Cash from Operations | 189.11% | 191.19% | -263.72% | -254.72% | -33.19% |
| Capital Expenditure | -23.17% | -26.02% | 34.04% | 35.65% | 71.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 56.21% | 55.18% | -118.89% | -113.52% | 25.99% |
| Cash from Investing | 37.35% | 35.88% | -33.64% | -30.35% | 46.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 76.62% | 76.62% | -484.46% | -484.46% | 3.66% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -118.50% | -118.93% | 528.63% | 518.08% | -4.49% |
| Foreign Exchange rate Adjustments | 299.04% | 303.70% | -8.04% | -5.34% | -409.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 163.22% | 169.36% | 167.02% | 165.37% | -29.04% |